Nancy-Ellen Haynes,Denis J. Kertesz,Sherrie Lynn Pietranico-Cole,Yimin Qian,Nathan Robert Scott,Sung-Sau So,Kshitij Chhabilbhai Thakkar,Jefferson Wright Tilley
申请号：
US14788921
公开号：
USRE046024E1
申请日:
2015.07.01
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Provided herein are compounds of the formula (I):as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as obesity, hyperlipidemia, hypercholesterolemia and diabetes and other related disorders and diseases, and may be useful for other diseases such as NASH, atherosclerosis, cardiovascular diseases, hypothyroidism, thyroid cancer and other disorders and diseases related thereto.
